(2021)
Results from the German fungal keratitis registry: Significant differences between cases with and without a history of contact lens use.
Cornea 40(11),
1453-1461.

Marie von Lilienfeld-Toal
National Reference Center for Invasive Fungal Infections Infections in Hematology/Oncology +49 3641 532-1720 marie.lilienfeld-toal@leibniz-hki.deCurriculum vitae
Main Research Areas
- Tumour and infection immunology
- Epidemiology of infections of von Infektionen immunosuppressed patients
- Clinical diagnostic and therapeutical studies
Professional Career
2014 | Deputy head of the Nationales Referenzzentrum für invasive Pilzinfektionen |
2013 | W2-professorship in infection research in haematology and oncology, medical faculty, Friedrich-Schiller University Jena |
2010 | Habilitation in internal medicine, Rheinische Friedrich-Wilhelms University Bonn |
2008-2013 | Senior physician in the dept. haematology / oncology (med. clinic III), University Hospital, Bonn |
2007-2008 | EBMT Fellowship Bone Marrow Transplantation Programme, Leeds, UK |
2007 | Acceptance of the priority area haematology / oncology |
2006 | Specialist in internal diseases |
2003-2004 | Gerok fellowship within the BonFor funding programme, medical faculty Bonn |
1999-2007 | Doctor in practical training (AiP) /assistant physician in internal medicine, University Hospital Bonn |
1999 | PhD in clinical pharmacology, „magna cum laude“, medical faculty, Rheinische Friedrich-Wilhelms University Bonn |
1998 | Staatsexamen (state examination) human medicine |
Awards · Appointments · Scientific Activities
Since 2013 | Member of the ethics commission, medical faculty of the FSU Jena |
Since 2013 | Board member of the working group dealing with infections in haematology and oncology (AGIHO) of the Deutsche Gesellschaft für Hämatologie und internistische Onkologie (DGHO) |
Since 2008 | Member of the AGIHO |
2008-2010 | Assistant lecturer at the medical clinic III of the University Hospital Bonn |
2002-2006 | Member of the statutes commission of the medical faculty of the Rheinische Friedrich-Wilhelms University Bonn |
2009 | Best abstract DGHO |
2008 | Poster award |
Since 2004 | Assessor of several magazines |
Publications
(2021)
COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
Ann Hematol 100(2),
383-393.
(2021)
Eye infections caused by filamentous fungi: Spectrum and antifungal susceptibility of the prevailing agents in germany.
J Fungi (Basel) 7(7),
511.
(2020)
Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN).
J Cancer Res Clin Oncol 146(3),
749-759.
(2020)
Frequency of infections in 948 MPN patients: A prospective multicenter patient-reported pilot study.
Leukemia 34(7),
1949-1953.
(2020)
Long-term follow-up of Cladribine, high-dose Cytarabine, and Idarubicin as salvage treatment for relapsed acute myeloid leukemia and literature review.
Eur J Haematol 104(6),
538-545.
(Review)
(2020)
Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the international forum for optimizing care of older adults with myeloma.
J Geriatr Oncol 11(5),
764-768.
(2020)
Detection of community-acquired respiratory viruses in allogeneic stem-cell transplant recipients and controls-A prospective cohort study.
Transpl Infect Dis 22(6),
e13415.
(2020)
Treatment of invasive fungal diseases in cancer patients-Revised 2019 recommendations of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Mycoses 63(7),
653-682.
(2020)
Human neutrophils produce antifungal extracellular vesicles against Aspergillus fumigatus.
mBio 11(2),
e00596-20.